The PREPARE study: benefits of pharmacogenetic testing are unclear
Lancet
.
2023 Jun 3;401(10391):1850-1851.
doi: 10.1016/S0140-6736(23)00854-1.
Author
David Curtis
1
Affiliation
1
UCL Genetics Institute, UCL, London WC1E 6BT, UK. Electronic address: d.curtis@ucl.ac.uk.
PMID:
37270235
DOI:
10.1016/S0140-6736(23)00854-1
No abstract available
Publication types
Letter
Comment
MeSH terms
Genetic Testing*
Humans
Pharmacogenetics
Pharmacogenomic Testing*